ERVW-1 and infection: Recently, we vaccinated two groups of Mamu-B*17+ RMs with vif and nef, with and without the addition of env. Interestingly, the group that received env, vif, and nef showed unprecedented rapid control of SIVmac239 after infection, highlighting the potential role of vaccine-induced, non-neutralizing Abs in suppressing viremia.